Trial
NCT06845943
A First-in-human Study of HCR-188 in Overweight or Obese Otherwise Healthy Volunteers Without Type 2 Diabetes
Early Phase ISUSPENDEDOPERATIONALConfidence: HIGH
Sponsor
Helicore Biopharma, Inc.
Collaborators
—
Condition
Obesity and Overweight
Intervention
HCR-188
Why stopped
Business decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-11-26